Application of high-dose intravenous iron in the treatment of anemia in pregnant and postpartum women
TENG Xin-yuan
WANG Li-quan
Abstract：Anemia during pregnancy and the postpartum period is a global public health issue,significantly associated with adverse obstetric outcomes,and iron deficiency(ID)is its primary cause.Currently,novel high-dose intravenous iron formulations,which allow single-dose infusion of ≥1000 mg within 15-30 minutes,have been approved for clinical use in China.However,obstetricians and gynecologists lack sufficient understanding of their efficacy and safety in pregnant and postpartum women.This article discusses the application of high-dose intravenous iron in pregnant and postpartum women.
Keywords：high-dose intravenous ironpregnant and postpartum womenanemiaclinical application
Publication Date：2025-10-02
Online Publishing Date：2025-11-19(First online date of this platform, not the publication date of the document)
Pages：4( 986-989 )